when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Cell Therapy · news · pharmadog

← back to Cell Therapy

News · Cell Therapy

122 stories

May 13, 26#ASGCT26: Tessera reveals strongest data yet for in vivo sickle cell therapyendpoints

May 13, 26BRUIN CLL-321 Trial Impact and Treatment Selectiononclive

May 13, 26Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapyonclive

May 12, 26Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanomaonclive

May 12, 26Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanomaonclive

May 12, 26Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Riskonclive

May 12, 26GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026onclive

May 12, 26Unmet Needs in Endometrial Canceronclive

May 12, 26EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCsonclive

May 12, 26Future Directions in Relapsed and Refractory Multiple Myelomaonclive

May 12, 26Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Canceronclive

May 12, 26Sequencing Strategies After Progression in Multiple Myelomaonclive

May 12, 26EGFR-Mutated NSCLC: Targeting MET-Driven Resistance in Second-Line Therapyonclive

May 12, 26Sequencing ADCs in Endometrial Canceronclive

May 12, 26Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive

May 11, 26MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive

May 11, 26New home for Novo's Parkinson's cell therapy; GSK's deal to sell drug in Chinaendpoints

May 11, 26FDA Approval of Brexu-Cel for R/R MCL Calls for Raised Awareness of CAR T-Cell Therapy Safety Considerationsonclive

May 11, 26Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trialbiopharma dive

May 8, 26OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive

May 8, 26FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extendedbiopharma dive

May 8, 26STAT+: The biotech news you need to read todaystat

May 8, 26Lilly, Gilead lead pharma’s M&A boombiopharma dive

May 8, 26Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCLonclive

May 8, 26Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prependpoints

May 7, 26Astellas touts data from early test of stem cell-derived eye therapyendpoints

May 7, 26Atara, Pierre Fabre's cell therapy to get another shot at FDA approvalendpoints

May 7, 26Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026onclive

May 5, 26Cytospire hauls in $83M for a new type of T cell engagerbiopharma dive

May 4, 26Opinion: Mifepristone court ruling makes drug development riskier for everyonestat

← prevpage 4 of 5next →